Disease Info Card

Childhood Medulloblastoma

Information about Childhood Medulloblastoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Childhood Medulloblastoma

Most recent studies have shown that Childhood Medulloblastoma shares some biological mechanisms with brain-neoplasms, central-nervous-system-neoplasms, cerebellar-neoplasms, childhood-brain-neoplasm, cognition-disorders, desmoplastic, ependymoma, glioma, malignant-neoplasm-of-brain, malignant-neoplasms, malignant-paraganglionic-neoplasm, medulloblastoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, neuroectodermal-tumor-primitive, neuroectodermal-tumors, residual-tumor-(qualifier-value), sequelae-aspects.

Among the many pathways, these few ones have gauged particular interests from scientists studying Childhood Medulloblastoma, and have been seen in publications frequently: Angiogenesis, Brain Development, Cell Adhesion, Cell Cycle, Cell Cycle Arrest, Cell Death, Cell Growth, Cell Killing, Cell Migration, Cell Proliferation, Dna Amplification, Dna Methylation, Dna Repair, Induction Of Apoptosis, Localization, Methylation, Pathogenesis, Secretion, Segmentation, Tissue Remodeling

Quite a number of genes have been found to play important roles in Childhood Medulloblastoma, such as BCL2, COL9A1, COL9A3, COMP, CSF2, ERBB4, GH1, LAMC2, MB, MID1, MYC, MYCN, NTRK3, PARP1, SCN8A, SHH, TP53. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.